Mithra Pharmaceuticals SA (MITPF)
6.75
0.00 (0.00%)
USD |
OTCM |
Nov 22, 16:00
Mithra Pharmaceuticals Total Liabilities (Quarterly): 416.74M for June 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 416.74M |
| June 30, 2023 | 416.74M |
| December 31, 2022 | 438.32M |
| June 30, 2022 | 414.05M |
| June 30, 2022 | 414.05M |
| December 31, 2021 | 439.39M |
| June 30, 2021 | 402.84M |
| June 30, 2021 | 402.84M |
| December 31, 2020 | 448.01M |
| June 30, 2020 | 263.10M |
| June 30, 2020 | 263.10M |
| December 31, 2019 | 262.51M |
| June 30, 2019 | 348.45M |
| June 30, 2019 | 348.45M |
| Date | Value |
|---|---|
| December 31, 2018 | 238.89M |
| June 30, 2018 | 193.82M |
| June 30, 2018 | 193.82M |
| December 31, 2017 | 189.35M |
| June 30, 2017 | 131.40M |
| June 30, 2017 | 131.40M |
| December 31, 2016 | 84.24M |
| June 30, 2016 | 81.58M |
| June 30, 2016 | 81.58M |
| December 31, 2015 | 85.49M |
| June 30, 2015 | 43.14M |
| June 30, 2015 | 43.14M |
| December 31, 2014 | 12.37M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
262.51M
Minimum
Dec 2019
448.01M
Maximum
Dec 2020
381.81M
Average
414.05M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Galapagos NV | 1.463B |
| UCB SA | 7.156B |
| Nyxoah SA | 42.51M |
| Celyad Oncology SA | 12.13M |
| MDxHealth SA | 140.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 407.25M |
| Shareholders Equity (Quarterly) | -9.487M |
| Debt to Equity Ratio | -19.15 |
| Current Ratio | 1.043 |
| Net Debt Paydown Yield | 1.08% |